26.72
price up icon1.75%   0.46
after-market After Hours: 26.72
loading
Celldex Therapeutics Inc stock is traded at $26.72, with a volume of 461.41K. It is up +1.75% in the last 24 hours and up +4.37% over the past month. Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
See More
Previous Close:
$26.26
Open:
$26.62
24h Volume:
461.41K
Relative Volume:
0.38
Market Cap:
$1.77B
Revenue:
$5.79M
Net Income/Loss:
$-199.61M
P/E Ratio:
-8.8771
EPS:
-3.01
Net Cash Flow:
$-188.48M
1W Performance:
-0.41%
1M Performance:
+4.37%
6M Performance:
+36.47%
1Y Performance:
-5.01%
1-Day Range:
Value
$26.18
$26.77
1-Week Range:
Value
$25.97
$28.59
52-Week Range:
Value
$14.40
$29.38

Celldex Therapeutics Inc Stock (CLDX) Company Profile

Name
Name
Celldex Therapeutics Inc
Name
Phone
908-200-7500
Name
Address
53 FRONTAGE ROAD, HAMPTON
Name
Employee
186
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
CLDX's Discussions on Twitter

Compare CLDX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CLDX
Celldex Therapeutics Inc
26.72 1.74B 5.79M -199.61M -188.48M -3.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.39 108.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.43 60.82B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.95 61.02B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
817.32 50.01B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.81 34.05B 4.56B -176.77M 225.30M -1.7177

Celldex Therapeutics Inc Stock (CLDX) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-21-25 Initiated Mizuho Outperform
Oct-13-25 Initiated Barclays Underweight
Apr-28-25 Initiated Canaccord Genuity Buy
Mar-20-25 Initiated Morgan Stanley Overweight
Feb-13-25 Initiated UBS Buy
Oct-07-24 Initiated Citigroup Buy
Sep-30-24 Initiated Goldman Neutral
Sep-27-24 Downgrade Wolfe Research Outperform → Peer Perform
Jun-18-24 Initiated Stifel Buy
Jun-11-24 Initiated Wolfe Research Outperform
Dec-20-23 Initiated TD Cowen Outperform
Nov-10-23 Upgrade Wells Fargo Underweight → Equal Weight
Aug-22-23 Initiated Wells Fargo Underweight
Sep-17-21 Initiated Jefferies Buy
Sep-10-21 Initiated SVB Leerink Outperform
Jul-22-21 Initiated Guggenheim Buy
Feb-21-20 Initiated Cantor Fitzgerald Overweight
Aug-01-17 Resumed H.C. Wainwright Buy
Nov-07-16 Initiated Aegis Capital Buy
Mar-08-16 Downgrade Jefferies Buy → Hold
Mar-07-16 Downgrade Guggenheim Buy → Neutral
Mar-07-16 Downgrade Leerink Partners Outperform → Mkt Perform
Mar-07-16 Downgrade Wedbush Outperform → Neutral
Mar-01-16 Initiated H.C. Wainwright Buy
Aug-11-15 Reiterated Brean Capital Buy
Aug-11-15 Reiterated Oppenheimer Outperform
Aug-11-15 Reiterated ROTH Capital Buy
Jun-02-15 Reiterated WBB Securities Strong Buy
Nov-17-14 Reiterated ROTH Capital Buy
Mar-04-14 Reiterated Oppenheimer Outperform
Jul-08-13 Reiterated Cantor Fitzgerald Buy
Mar-08-13 Reiterated Cantor Fitzgerald Buy
Feb-26-13 Reiterated Oppenheimer Outperform
Jan-10-13 Reiterated Cantor Fitzgerald Buy
Oct-02-12 Reiterated Oppenheimer Outperform
Sep-14-12 Reiterated Cantor Fitzgerald Buy
View All

Celldex Therapeutics Inc Stock (CLDX) Latest News

pulisher
01:01 AM

What momentum shifts mean for Celldex Therapeutics Inc.2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com

01:01 AM
pulisher
12:59 PM

Real time alert setup for Celldex Therapeutics Inc. performanceJuly 2025 Market Mood & Scalable Portfolio Growth Ideas - newser.com

12:59 PM
pulisher
12:41 PM

Will Celldex Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Action & Verified Entry Point Detection - newser.com

12:41 PM
pulisher
Oct 25, 2025

What’s next for Celldex Therapeutics Inc. stock price2025 Biggest Moves & AI Forecast for Swing Trade Picks - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Why analysts remain bullish on Celldex Therapeutics Inc. stockMarket Weekly Review & Free High Accuracy Swing Entry Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Is Celldex Therapeutics Inc. stock a bargain at current levelsPortfolio Update Summary & Safe Capital Growth Tips - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Can Celldex Therapeutics Inc. stock reach $100 price targetJuly 2025 Market Mood & AI Driven Stock Price Forecasts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Chart overlay techniques for tracking Celldex Therapeutics Inc.Weekly Investment Recap & Community Verified Trade Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Published on: 2025-10-25 11:53:34 - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

How Celldex Therapeutics Inc. (TCE2) stock trades in high volatilityMarket Movers & Verified Technical Signals - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Is it too late to sell Celldex Therapeutics Inc.Weekly Market Summary & Weekly High Potential Stock Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Published on: 2025-10-25 02:57:01 - newser.com

Oct 25, 2025
pulisher
Oct 24, 2025

Published on: 2025-10-24 02:30:04 - newser.com

Oct 24, 2025
pulisher
Oct 23, 2025

Celldex Therapeutics Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 23, 2025
pulisher
Oct 23, 2025

Published on: 2025-10-23 07:06:05 - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Celldex Therapeutics (CLDX): Evaluating Valuation After Barclays' Underweight Rating and Industry Concerns - Yahoo Finance

Oct 23, 2025
pulisher
Oct 22, 2025

Celldex Therapeutics Receives Bullish Analyst Coverage Amid Pipeline Developments - AD HOC NEWS

Oct 22, 2025
pulisher
Oct 22, 2025

Will Celldex Therapeutics Inc. (TCE2) stock hit Wall Street targetsJobs Report & High Return Trade Guides - newser.com

Oct 22, 2025
pulisher
Oct 22, 2025

Is Celldex Therapeutics Inc. reversing from oversold territoryMarket Growth Review & Weekly Market Pulse Alerts - newser.com

Oct 22, 2025

Celldex Therapeutics Inc Stock (CLDX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.26
price up icon 1.11%
$91.28
price up icon 2.21%
$29.89
price up icon 0.07%
$105.66
price up icon 0.87%
$159.66
price down icon 0.29%
biotechnology ONC
$310.81
price up icon 0.25%
Cap:     |  Volume (24h):